Stephen Martinez1, Alexander Brandl1, Del Leary1. 1. Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Abstract
PURPOSE: Most solid tumors contain areas of chronic hypoxia. Gold nanoparticles (GNP) have been extensively explored as enhancers of external beam radiation; however, GNP have lower cellular uptake in hypoxic conditions than under normoxic conditions. Conversely, the chelator diacetyl-bis (N(4)-methylthiosemicarbazonato) copper II (CuATSM) deposits copper in hypoxic regions, allowing for dose enhancement in previously inaccessible regions. METHODS: External beam sources with different spectra were modeled using a Monte Carlo code (EGSnrc) to evaluate radioenhancement in a layered model with metal solutions. Also considered was a simple concentric layered tumor model containing a hypoxic core with each layer varying in concentrations of either copper or gold according to hypoxic conditions. Low energy external photon beams were then projected onto the tumor to determine the regional dose enhancement dependent on hypoxic conditions. RESULTS: Dose enhancement was more pronounced for beam spectra with low energy photons (225 kVp) and was highly dependent on metal concentrations from 0.1 g/kg to 100 g/kg. Increasing the depth of the metallic solution layer from 1 cm to 6 cm decreased dose enhancement. A small increase in the dose enhancement factor (DEF) of 1.01 was predicted in the hypoxic regions of the tumor model with commonly used diagnostic concentrations of CuATSM. At threshold concentrations of toxic subcutaneous injection levels, the DEF increases to 1.02, and in simulation of a high concentration of CuATSM, the DEF increased to 1.07. High concentration treatments are also considered, as well as synergistic combinations of GNP/CuATSM treatments. CONCLUSION: The research presented is novel utilization of CuATSM to target hypoxic regions and act as a radiosensitizer by the nature of its ability to deposit copper metal in reduced tissue. We demonstrate CuATSM at high concentrations with low energy photons can increase dose deposition in hypoxic tumor regions.
PURPOSE: Most solid tumors contain areas of chronic hypoxia. Gold nanoparticles (GNP) have been extensively explored as enhancers of external beam radiation; however, GNP have lower cellular uptake in hypoxic conditions than under normoxic conditions. Conversely, the chelator diacetyl-bis (N(4)-methylthiosemicarbazonato) copper II (CuATSM) deposits copper in hypoxic regions, allowing for dose enhancement in previously inaccessible regions. METHODS: External beam sources with different spectra were modeled using a Monte Carlo code (EGSnrc) to evaluate radioenhancement in a layered model with metal solutions. Also considered was a simple concentric layered tumor model containing a hypoxic core with each layer varying in concentrations of either copper or gold according to hypoxic conditions. Low energy external photon beams were then projected onto the tumor to determine the regional dose enhancement dependent on hypoxic conditions. RESULTS: Dose enhancement was more pronounced for beam spectra with low energy photons (225 kVp) and was highly dependent on metal concentrations from 0.1 g/kg to 100 g/kg. Increasing the depth of the metallic solution layer from 1 cm to 6 cm decreased dose enhancement. A small increase in the dose enhancement factor (DEF) of 1.01 was predicted in the hypoxic regions of the tumor model with commonly used diagnostic concentrations of CuATSM. At threshold concentrations of toxic subcutaneous injection levels, the DEF increases to 1.02, and in simulation of a high concentration of CuATSM, the DEF increased to 1.07. High concentration treatments are also considered, as well as synergistic combinations of GNP/CuATSM treatments. CONCLUSION: The research presented is novel utilization of CuATSM to target hypoxic regions and act as a radiosensitizer by the nature of its ability to deposit copper metal in reduced tissue. We demonstrate CuATSM at high concentrations with low energy photons can increase dose deposition in hypoxic tumor regions.
Authors: Suneil Jain; Jonathan A Coulter; Alan R Hounsell; Karl T Butterworth; Stephen J McMahon; Wendy B Hyland; Mark F Muir; Glenn R Dickson; Kevin M Prise; Fred J Currell; Joe M O'Sullivan; David G Hirst Journal: Int J Radiat Oncol Biol Phys Date: 2010-11-20 Impact factor: 7.038
Authors: P R Noel; K C Barnett; R E Davies; D W Jolly; J S Leahy; L E Mawdesley-Thomas; K W Shillam; P F Squires; A E Street; W C Tucker; A N Worden Journal: Toxicology Date: 1975 Impact factor: 4.221
Authors: Jared R Williams; Emiliano Trias; Pamela R Beilby; Nathan I Lopez; Edwin M Labut; C Samuel Bradford; Blaine R Roberts; Erin J McAllum; Peter J Crouch; Timothy W Rhoads; Cliff Pereira; Marjatta Son; Jeffrey L Elliott; Maria Clara Franco; Alvaro G Estévez; Luis Barbeito; Joseph S Beckman Journal: Neurobiol Dis Date: 2016-01-27 Impact factor: 5.996
Authors: Dayton D McMillan; Junko Maeda; Justin J Bell; Matthew D Genet; Garrett Phoonswadi; Kelly A Mann; Susan L Kraft; Hisashi Kitamura; Akira Fujimori; Yukie Yoshii; Takako Furukawa; Yasuhisa Fujibayashi; Takamitsu A Kato Journal: J Radiat Res Date: 2015-08-06 Impact factor: 2.724